Rubric Capital Management LP Ovid Therapeutics Inc. Transaction History
Rubric Capital Management LP
- $3.49 Billion
- Q1 2025
A detailed history of Rubric Capital Management LP transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 5,315,969 shares of OVID stock, worth $2.55 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,315,969
Previous 5,315,969
-0.0%
Holding current value
$2.55 Million
Previous $4.94 Million
66.68%
% of portfolio
0.05%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding OVID
# of Institutions
85Shares Held
39.7MCall Options Held
1.7KPut Options Held
100-
Black Rock Inc. New York, NY3.99MShares$1.92 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$1.85 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.11MShares$1.49 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.47MShares$1.18 Million0.1% of portfolio
-
Sio Capital Management, LLC New York, NY2.23MShares$1.07 Million0.26% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $33.8M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...